Helping asthma sufferers breathe easier
Dr. Diane Loughheed, MSc’99, (MD’86, McMaster) is a Professor in the Departments of Medicine, Physiology, and Community Health and Epidemiology. She is also an Adjunct Scientist with the Institute forClinical Evaluative Sciences (ICES) at ICES-Queen’s and Director of the Asthma Research Unit in the Clinical Research Centre at Kingston General Hospital (KGH) In addition to her academic responsibilities, she is a Staff Respirologist at KGH and Hotel Dieu Hospital (HDH), Director of the KGH Asthma Program, and Director of the Adult Cystic Fibrosis Clinic at Kingston’s Hotel Dieu Hospital
Lougheed’s primary research and clinical interests are asthma and adult cystic fibrosis. Her research is focused primarily on asthma physiology and epidemiology. Of this disease, she says, “Asthma is one of the most common chronic conditions, affecting approximately eight per cent of adults and 12 per cent of children in Canada.” She also participates in multi-centre studies of cystic fibrosis."Cystic Fibrosis is one of the most common genetic diseases. The HDH Adult and Pediatric CF Clinics contribute data to the Canadian CF Foundation Registry. The registry data shows that the median survival is now 46 years, largely attributable to better nutrition and improved management of CF lung disease," she says.
Lougheed has been funded by the Government of Ontario’s Asthma Plan of Action to research emergency department asthma care pathways and pilot primary care asthma electronic records. She was recently awarded two key grants. She is the principal investigator of a $600,000 Team Grant funded by AllerGen NCE Inc., a network of researchers studying asthma and allergy-related illnesses. Lougheed’s project will investigate the burden of work-related asthma and allergy. She is also the recipient of a $225,000 Academic Health Sciences Centre (AHSC) AFP Innovation Fund grant to develop a Southeastern Ontario asthma care network.
“We are engaging and collaborating with local care providers and stakeholders to devise, implement and evaluate a novel chronic disease care model. We hope that the use of electronic knowledge translation tools will promote evidence-based asthma care, address local care gaps, and optimize asthma care delivery and outcomes in our region.”